Moderna Inc. reached a deal with the US to manufacture and distribute 100 million doses of its experimental vaccine for Covid-19, in a pact valued up to $1.5 billion, the company said Tuesday.

{{^htLoading}} {{/htLoading}}
“I’m pleased to announce we’ve reached an agreement with Moderna to manufacture and deliver 100m doses of the coronavirus vaccine candidate,” President Donald Trump said at a White House briefing. “We’re on track to rapidly produce 100 million doses as soon as the vaccine is approved.”
{{^usCountry}} {{/usCountry}}
It’s the latest in a string of supply deals reached to stockpile the most advanced vaccines in testing.
Moderna shares gained 8.5% to $74.80 in late trading in New York.
Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
Advertisement
{{/htLoading}}{{#usCountry}} {{/usCountry}}